Clinigen Group Further Strengthens Oncology Support Portfolio with Acquisition of Ethyol® (amifostine), from AstraZeneca
CTS Announces Second Quarter 2014 Results
Magna Announces Second Quarter and Year to Date Results
IMRIS receives CE mark for integrating latest generation MR scanners within VISIUS Surgical Theatre in European market
UPDATE: GM to recall additional 717,950 vehicles
Pepco deal, power prices, capacity markets, carbon caps: It’s been a wild ride for Exelon in 2014.
The new General Motors is much leaner than its predecessor, and any near-term litigation risk will have little impact on the automaker's 1.85 billion diluted shares.
Our fair value estimate and moat rating remain intact.
Even after a strong rebound from the market trough in 2009, the U.S. auto sector still has room to run.
Wasatch's Sam Stewart looks for companies that do things so differently that they can change an industry forever.